Lung Cancer
Article
Factors Associated with Radiation Toxicity and Survival in Patients with Presumed Early-Stage Non-Small Cell Lung Cancer Receiving Empiric Stereotactic Ablative Radiotherapy
In a retrospective chart review of patients who were not biopsied for expected NSCLC because of poor pulmonary function, the use of empiric...
Article
The power and promise of social media in oncology
Dr. Alan Lyss describes a recent presentation on the role of social media in oncology.
Article
Radiotherapeutic Care of Patients With Stage IV Lung Cancer with Thoracic Symptoms in the Veterans Health Administration
VHA radiation oncologists reported that their practices were concordant with American Society for Radiation Oncology guidelines on palliative...
Conference Coverage
Superior survival with sintilimab in squamous NSCLC
Sintilimab improved overall and progression-free survival, when compared with docetaxel.
News
FDA moves to ban menthol in cigarettes
News
Survival benefit with nivolumab extends to 5 years in NSCLC
Early response portends durable outcome, but the optimal duration of treatment is uncertain.
Article
Leveraging the microbiome to enhance cancer treatment
Dr. Alan Lyss reviews research suggesting that an antibiotic can improve the efficacy of radiotherapy.
Conference Coverage
Personalized cancer vaccine shows early promise across tumor types
The vaccine consists of patient-specific synthetic neoantigen peptides and is given to patients in the adjuvant setting.
Latest News
Rankings of most common cancers to shift over next 20 years
“It’s time to shift focus to some of the less commonly diagnosed cancers with the lowest survival rates, like pancreatic and liver cancer.”
News
Increased cancer risk from night shift due to gene dysregulation?
A simulated night shift schedule significantly altered the normal circadian rhythmicity of genes.